Abbott Laboratories Diagnostics Division, Abbott Park, Illinois 60064 USA - Manufacturer Profile
Explore comprehensive manufacturer profile for Abbott Laboratories Diagnostics Division, Abbott Park, Illinois 60064 USA through Pure Global AI's free Albania medical device database. This company manufactures 15 medical devices registered in Albania across 1 risk class. Their registration history spans from Jan 04, 2018 to Oct 29, 2019.
This page provides detailed insights including recent registrations, risk class distribution (Invitro: 15), and complete regulatory information from the official Albania medical device database. Pure Global AI offers free access to Albania's complete medical device registry.
Free Manufacturer Profile
Powered by Pure Global AI
15 Devices
1 Risk Classes
Abbott Laboratories Diagnostics Division, Abbott Park, Illinois 60064 USA
Manufacturer
15
Total Devices
1
Risk Classes
2018
Earliest
2019
Latest
Recent Registrations
Latest 10 Albania device registrations
Architect Tacrolimus Whole Blood Precipitation Reagent: 1L77-55
6260
Invitro
Oct 29, 2019
Lipase Calibrator: 3E16-02
6255
Invitro
Oct 29, 2019
Cell-Dyn CN-Free HGB/NOC Lyse: 03H80-02
6256
Invitro
Oct 29, 2019
Transplant Pretreament Tubes: 1P06-02
6259
Invitro
Oct 29, 2019
ARCHITECT Cortisol Calibrators: 8D15-25
6083
Invitro
Sep 26, 2019
Architect c8000 PROCESSING MODULE 01G06-11; Architect c8000 ADD-ON Retest Samples Handler 02J47-40; 02J47-41; Architect c8000 Stand Alone Retest Samples Handler 02J47-52; Architect c8000/c16000 Card Cage and Cables 02J47-75; ARCHITECT cSYSTEMS ICT MODULE 09D28-03; ARCHITECT c8000 ICT MODULE 09D28-03; ARCHITECT c8000 SKINS FIT 01G06-12; ARCHITECT c8000 LAS STANDART KIT 07L18-12;
4908
Invitro
Feb 18, 2019
Architect i1000SR Processing Module 01L86-01; Architect i1000SR Integrated Module 01L86-40
4904
Invitro
Feb 18, 2019
Architect i2000SR Processing Module 03M74-02
4905
Invitro
Feb 18, 2019
Immunoglobulin M 1E0121
4355
Invitro
Nov 01, 2018
Transferrin
4348
Invitro
Oct 26, 2018
Risk Class Distribution
Devices by risk class
Invitro
15
100.0% of total